Enervit SpA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IT0004356751
EUR
3.76
-0.06 (-1.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Enervit SpA stock-summary
stock-summary
Enervit SpA
Pharmaceuticals & Biotechnology
Enervit SpA is an Italy-based company engaged in the sports and nutrition market. It researches, develops and commercializes food supplements. The Company’s product lines include Enervit, a line of supplements for sport, efficiency, and muscular recovery before, during and after sports activity; Enerzona, a food supplement line that targets the wellness market, which includes snacks, diet food and drinks, among others; EnervitProtein, which includes products aimed at the Health & Diet market; Gymline, which is a product line allowing to maintain the muscle tone and muscle development. It operates an online shop. Its products are exported to over 20 countries globally. Its products are manufactured in facility located in Zelbio in Italy. It operates through Zest 12 SA, Equipe Enervit Srl and SLORFELDT TRADING AB.
Company Coordinates stock-summary
Company Details
Viale Achille Papa, 30 , MILANO None : 20149
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Alberto Sorbini
Chairman of the Board, Chief Executive Officer
Mr. Giuseppe Sorbini
Chief Executive Officer, Director
Ms. Maurizia Sorbini
Executive Director
Ms. Erica Alessandri
Director
Mr. Stefano Baldini
Director
Mr. Carlo Capelli
Non-Executive Director
Mr. Maurizio Cereda
Independent Director
Mr. Ciro Cornelli
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Dec 2015)
Net Profit:
0 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 69 Million ()

stock-summary
P/E

82.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.15

stock-summary
Return on Equity

3.08%

stock-summary
Price to Book

2.11